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ﻥﻮﻜﺘﺗﻭﺓﻮﺧﺮﻟﺍﺞﺴﻨﻠﻟﺓﺭﺩﺎﻧًﺎﻣﺍﺭﻭﺃﺔﻴﻓﺮﻄﻟﺍﺏﺎﺼﻋﻷﺍﺪﻤﻐﻟﺔﺜﻴﺒﺨﻟﺍﻡﺍﺭﻭﻷﺍﺮﺒﺘﻌﺗ
ﻩﺬﻫﻢﻈﻌﻣﻭ.ﺔﻴﻓﺮﻄﻟﺍﺏﺎﺼﻋﻷﺍﻦﻣﺔﺌﺷﺎﻧﻞﻜﺸﻟﺍﺔﻴﻟﺰﻐﻣﺔﻴﻧﺎﻃﺮﺳﺎﻳﻼﺧﻦﻣ
ﺓﺪﻴﺳﺖﻟﻮﺣ.ﺔﺒﻗﺮﻟﺍﻭﺱﺃﺮﻟﺍﺔﻘﻄﻨﻣﻲﻓﺓﺭﺩﺎﻧﺮﺒﺘﻌﺗﻭﻑﺍﺮﻃﻷﺍﻰﻠﻋﺄﺸﻨﺗﻡﺍﺭﻭﻷﺍ
،ﺔﻴﻔﻧﺃﺕﺍﺯﺍﺮﻓﺇﻭﻒﻧﻸﻟﺩﺍﺪﺴﻧﺍﻦﻣﻲﻧﺎﻌﺗﻰﻔﺸﺘﺴﻤﻟﺍﻰﻟﺇﺎﻣﺎﻋ٣٣ﺮﻤﻌﻟﺍﻦﻣﻎﻠﺒﺗ
ﻸﻤﺗﺔﻴﺠﻴﺴﻧﺔﻠﺘﻛﺩﻮﺟﻭﺺﺤﻔﻟﺍﺮﻬﻇﺃﺪﻗﻭ.ﻡﺎﻋﺓﺪﻤﻟﺎﻧﺎﻴﺣﺃﻡﺪﺑﺔﺑﻮﺤﺼﻣﻥﻮﻜﺗ
ﻪﻓﺍﺮﺤﻧﺍﺔﺒﺒﺴﻣﻲﻔﻧﻷﺍﺰﺟﺎﺤﻟﺍﻰﻠﻋﻂﻐﻀﺗﻭﻲﻔﻧﻷﺍﻒﻳﻮﺠﺘﻟﺍﻦﻣﻦﻤﻳﻷﺍﺀﺰﺠﻟﺍ
ﻦﻴﻌﻠﻟﺔﻴﺠﻴﺴﻨﻟﺍﺔﻠﺘﻜﻟﺍﺩﺍﺪﺘﻣﺍﺔﻴﻌﻄﻘﻤﻟﺍﺔﻌﺷﻷﺍﺕﺮﻬﻇﺃﺪﻗﻭ.ﺮﺴﻳﻷﺍﺐﻧﺎﺠﻠﻟﺓﺪﺸﺑ
ﺓﺫﻮﺧﺄﻤﻟﺍﺔﻋﺰﺨﻠﻟﺔﻴﺠﻴﺴﻨﻟﺍﺔﺳﺍﺭﺪﻟﺍﺖﻔﺸﻛﻭ.ﻦﻤﻳﻷﺍﺪﺨﻟﺍﺔﻘﻄﻨﻤﺑﻲﻔﻧﻷﺍﺐﻴﺠﻟﺍﻭ
ﺕﺍﺭﺎﺒﺘﺧﺎﺑﻩﺪﻴﻛﺄﺗﻢﺗﻭ،ﺔﻴﺒﺼﻌﻟﺍﻑﺍﺮﻃﻷﺍﺪﻤﻐﺑﺚﻴﺒﺧﻡﺭﻭﺩﻮﺟﻭﺔﻠﺘﻜﻟﺍﻦﻣ
ﻦﻋﻦﻤﻳﻷﺍﺪﺨﻠﻟﻲﻔﻧﻷﺍﺐﻴﺠﻠﻟﻲﻠﺧﺍﺪﻟﺍﺐﻧﺎﺠﻟﺍﻭﻡﺭﻮﻟﺍﻞﻳﺯﺃ.ﺔﻴﺠﻴﺴﻨﻟﺍﺔﻋﺎﻨﻤﻟﺍ
ﺙﻭﺪﺣﻥﻭﺩﺔﻀﻳﺮﻤﻟﺍﺖﻨﺴﺤﺗ.ﻡﺎﻌﻟﺍﺮﻳﺪﺨﺘﻟﺍﺖﺤﺗﺭﺎﻈﻨﻤﻟﺎﺑﻒﻧﻷﺍﻒﻳﺮﻃ
ﺎﺟﻼﻋﺔﻀﻳﺮﻤﻟﺍﺖﻘﻠﺗ.ﺱﺩﺎﺴﻟﺍﻡﻮﻴﻟﺍﻲﻓﻝﺰﻨﻤﻠﻟﺖﺟﺮﺧﻭﺔﺣﺍﺮﺠﻟﺍﺪﻌﺑﺕﺎﻔﻋﺎﻀﻣ
ﺕﺎﻣﻼﻋﻱﺃﺭﻮﻬﻇﻦﻴﻣﺎﻋﺓﺪﻤﻟﺔﻤﻈﻨﻤﻟﺍﺔﻴﺒﻄﻟﺍﺔﻌﺑﺎﺘﻤﻟﺍﺮﻬﻈﺗﻢﻟﻭ،ﺎﻳﻭﺎﻤﻴﻛ
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Malignant peripheral nerve sheath tumours are rare soft-
tissue tumours consisting of a spindle-cell malignancy
arising from a peripheral nerve. Most of these tumours
arise on the extremities and are rare in the head and neck
region. A 33-year-old woman patient was referred to our
hospital with progressive nasal obstruction and discharge
occasionally mixed with blood since 1 year. Anterior
rhinoscopy revealed a polypoid mass completely occu-
pying the right nasal cavity, with a grossly left-deviating
nasal septum. Computed tomography of the paranasal
sinuses revealed an expansile soft-tissue mass filling the
right nasal cavity, which extended to the right maxillary
sinus with an erosion of the right lamina papyracea and
an extension to the right orbit. Biopsy revealed the mass
to be a malignant peripheral nerve sheath tumour, which
was confirmed by immunohistochemical tests. The
tumour was removed under general anaesthesia by nasal
endoscopy and right medial maxillectomy. The patient
recovered uneventfully and was discharged on day-6 af-
ter. She was given chemotherapy and is under regular
follow-ups, with no recurrence of the disease since 2
years.
Keywords: Immunohistochemistry; Malignant peripheral
nerve sheath tumour; Nose and paranasal sinuses; Spindle
cell
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Malignant peripheral nerve sheath tumour of nose 239IntroductionMalignant nerve sheath tumours arising from peripheral
nerves or somatic soft tissues associated with the nerve
sheath are rare and have various clinico-pathological fea-
tures.1These sarcomas originate from Schwann cells,
perineural cells or fibroblasts.2As these tumours can arise
from multiple cell types, their appearance varies widely
from one case to another, making diagnosis difficult. In
general, a sarcoma arising from a peripheral nerve or a
neurofibroma is considered to be a malignant peripheral
nerve sheath tumour, which often includes malignant
schwannomas, neurofibrosarcomas or neurogenic
sarcomas.3They are usually found in the lower extremities
and retroperitonium and rarely occur in the head and neck
region.4e7 These malignant sarcomas are locally invasive,
frequently leading to multiple recurrences and eventual
pulmonary and visceral metastatic spread.8
Malignant peripheral nerve sheath tumours arising from a
peripheral nerve are easily diagnosed at an advanced stage,
when distant metastases have developed. These tumours are
rare, with an incidence of 1:100 000; often 10% of patients
have a history of radiotherapy,9 as compared with 72e78%
for other sarcomas.10 Cases of this tumour constitute 5% of
all sarcomas, the sciatic nerve being most often affected.10
Malignant peripheral nerve sheath tumours include
heterologous mesenchymal and epithelial elements with
increased mitotic activity. Although surgical resection
remains the main treatment for these tumours, a complete
surgical resection is rarely possible. Metastasis occurs in
39% patients, and 68% die from this type of tumour.11
As known, the prognosis depends on the tumour size (less
favourable for tumours >5 cm), the histological grade and
the resection margin during surgery.12 The diagnosis may be
missed unless clinical suspicion is high, but an
immunohistochemistry test for S-100 protein could often
confirm the diagnosis.
In the case described here, a proliferative malignant pe-
ripheral nerve sheath tumour was removed by nasal endos-
copy with right medial maxillectomy. The patient recovered
uneventfully after surgical removal of the tumour, and the
adjunct chemotherapy was given; she was followed up for 2
years and was still tumour-free.
Case report
A 33-year-old woman presented to the ear, nose and
throat outpatient department of our institute complaining of
progressive bilateral nasal obstruction and nasal discharge
occasionally mixed with blood since 1 year. There was no
diplopia or other loss of vision. Anterior rhinoscopy showed
a polypoid mass completely occupying the right nasal cavity,
with a grossly left-deviated nasal septum. Computed to-
mography of the paranasal sinuses revealed an expansile
soft-tissue mass filling the right nasal cavity, extending to the
right maxillary sinus with the erosion of the right lamina
papyracea and an extension to the right orbit (Figure 1). The
nasal septum was pushed to the left, and the left maxillary
sinus showed hypo-attenuation, suggesting the collection of
fluid without any intracranial extension. The tumour was
removed under general anaesthesia by nasal endoscopy with
a microdebrider, and a right medial maxillectomy wasperformed. Extensions of the mass into the right maxillary
sinus and the right orbit were also removed. Intravenous
ceftriaxone and amikacin were administered to the patient
throughout her hospital stay. The post-operative period was
uneventful, and the patient was discharged at the day-6 after
surgery. Biopsy confirmed that the mass was a malignant
peripheral nerve sheath tumour.
Histopathological examination of the excised specimen
revealed respiratory mucosa and normal mucosal glands in
the tumour tissue. Additionally, the tissue contained pleo-
morphic spindle-shaped cells with prominent serpentine
nuclei in round-to-polygonal epithelial cells and nucleoli were
arranged in fascicles and nests. Concomitantly, increased
mitosis, atypical mitotic figures and areas of necrosis were
also seen. Perivascular condensation of the tumour cells was
evident (Figure 2). Results from immunohistochemical
analysis suggested the presence of the protein S100, with an
immuno-reactive score of 2þ in spindle cells.
The patient was given a course of chemotherapy with a
regimen of doxorubicin and ifosfamide for addressing the
possibility of further courses of malignancy during the post-
operative period and was prescribed alkaline nasal douching
for 1 month. She had no clinical recurrence of the tumour
during the 2-year post-operative follow-up.Discussion
Histologically, malignant peripheral nerve sheath tu-
mours have an undefined appearance, although common
findings are spindle cells with a high mitotic rate and indis-
tinct cytoplasmic borders, arranged in bundles or fascicles.1
Analysis of aspirates with immunohistochemistry is useful
for the diagnosis of tumours of the nose and paranasal
sinuses in order to exclude fibrosarcomas and fibrous
histiocytomas, as malignant peripheral nerve sheath
tumours specifically demonstrate S-100 positivity. For a
proper diagnosis, however, biopsy of the specimen remains
the best option. Surgery is the preferred treatment, but
post-operative radio- and chemotherapy are included as
adjunctive therapy.13 Development of the tumour is
thought to be a multistep, multigene process with the loss
of the chromosome 17q arm sequence, resulting in an
incomplete inactivation of the NF1 gene. Previous studies
had showed that 20e50% of patients with this tumour
lacked the NF1 gene, and the lifetime risk for the tumour
in patients with this deletion was assessed as 8e13%.14
Further, the primary mode of tumour spread is
haematogenous, but the metastatic pulmonary spread is
common. There is a limited evidence of an association with
other tumour-prone disorders, as only case reports show
an association with P53 mutations.14
Surgical treatment includes wide local excision, and
radiotherapy/chemotherapy remains an essential corollary in
post-operative treatment of this tumour. These tumours
have, however, been reported to be radio-resistant, with no
clear evidence of benefit of post-operative radiotherapy.16
Chemotherapy is nevertheless is used in the treatment of
unresectable recurrent disease and metastases.16 The
reported 5-year survival rate after chemotherapy is 50e
65%.17 Additionally, the prognosis is worse in patients
associated with von Recklinghausen disease, with an
Figure 1: Computed tomography showing an expansile soft-tissue mass filling the right nasal cavity extending to the right maxillary sinus
with erosion of the right lamina papyracea and extension to the right orbit.
S.R. Das et al.240eventual 30% survival at 5 years.15 Our patient received
postoperative chemotherapy, with no disease recurrence up
to 2 years after surgery.
The local and distant recurrence rate of malignant pe-
ripheral nerve sheath tumours is reported to be 40e65%.13
Longer survival is correlated with complete surgical
excision, small tumour size (<5 cm) and the presence of a
low-grade component.18 A recent study recorded an
overall survival rate of 84% in patients treated at a
sarcoma centre, which was attributed to improved
imaging, leading to an early diagnosis, and an aggressive
treatment with radiation and chemotherapy.18 Advances
in imaging methods such as magnetic resonance imagingand position emission tomography lead to earlier disease
detection and characterisation. Further characterisation
of a tumour at molecular level would help the earlier
detection of disease and perhaps would land at a more
reliable prognosis. As our patient had no history of
previous benign pathology, a de novo origin of the tumour
should be considered.
In conclusion, the malignant peripheral nerve sheath
tumour indicated by clinical examination and the ad-hoc test
of the aspirate was confirmed by the post-hoc analysis of the
excised tumour with immunohistochemical procedures. It is
hoped that complete surgical resection was possible in this
case. An early diagnosis and surgical removal of the tumour,
Figure 2: Tumour tissue, comprising pleomorphic spindle-shaped cells with serpentine nuclei and round-to-polygonal epithelial-like cells
with prominent nucleoli arranged in fascicles and nests; increased mitosis with atypical mitotic figure and areas of necrosis.
Malignant peripheral nerve sheath tumour of nose 241followed by a suitable chemotherapy with a regimen of
doxorubicin and ifosfamide could save the patient.
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